Synthesis and biological evaluation of disubstituted pyrimidines as selective 5-HT2C agonists

Juhyeon Kim, Yoon Jung Kim, Ashwini M. Londhe, Ae Nim Pae, Hyunah Choo, Hak Joong Kim, Sun Joon Min

Research output: Contribution to journalArticle

Abstract

Here, we describe the synthesis of disubstituted pyrimidine derivatives and their biological evaluation as selective 5-HT2C agonists. To improve selectivity for 5-HT2C over other subtypes, we synthesized two series of disubstituted pyrimidines with fluorophenylalkoxy groups at either the 5-position or 4-position and varying cyclic amines at the 2-position. The in vitro cell-based assay and binding assay identified compounds 10a and 10f as potent 5-HT2C agonists. Further studies on selectivity to 5-HT subtypes and drug-like properties indicated that 2,4-disubstituted pyrimidine 10a showed a highly agonistic effect on the 5-HT2C receptor, with excellent selectivity, as well as exceptional drug-like properties, including high plasma and microsomal stability, along with low CYP inhibition. Thus, pyrimidine 10a could be considered a viable lead compound as a 5-HT2C selective agonist.

Original languageEnglish
Article number3234
JournalMolecules
Volume24
Issue number18
DOIs
Publication statusPublished - 2019 Sep 5

Fingerprint

Serotonin 5-HT2 Receptor Agonists
Pyrimidines
pyrimidines
evaluation
selectivity
Assays
synthesis
Receptor, Serotonin, 5-HT2C
Lead compounds
drugs
lead compounds
Pharmaceutical Preparations
Amines
magnetohydrodynamic stability
Serotonin
Derivatives
Plasmas
amines
pyrimidine
cells

Keywords

  • 5-HT receptor
  • Binding affinity
  • Cell-based assay
  • Disubstituted pyrimidine
  • Selectivity

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Synthesis and biological evaluation of disubstituted pyrimidines as selective 5-HT2C agonists. / Kim, Juhyeon; Kim, Yoon Jung; Londhe, Ashwini M.; Pae, Ae Nim; Choo, Hyunah; Kim, Hak Joong; Min, Sun Joon.

In: Molecules, Vol. 24, No. 18, 3234, 05.09.2019.

Research output: Contribution to journalArticle

Kim, Juhyeon ; Kim, Yoon Jung ; Londhe, Ashwini M. ; Pae, Ae Nim ; Choo, Hyunah ; Kim, Hak Joong ; Min, Sun Joon. / Synthesis and biological evaluation of disubstituted pyrimidines as selective 5-HT2C agonists. In: Molecules. 2019 ; Vol. 24, No. 18.
@article{02c8c80b05764eaaa2d9182f29ca97dc,
title = "Synthesis and biological evaluation of disubstituted pyrimidines as selective 5-HT2C agonists",
abstract = "Here, we describe the synthesis of disubstituted pyrimidine derivatives and their biological evaluation as selective 5-HT2C agonists. To improve selectivity for 5-HT2C over other subtypes, we synthesized two series of disubstituted pyrimidines with fluorophenylalkoxy groups at either the 5-position or 4-position and varying cyclic amines at the 2-position. The in vitro cell-based assay and binding assay identified compounds 10a and 10f as potent 5-HT2C agonists. Further studies on selectivity to 5-HT subtypes and drug-like properties indicated that 2,4-disubstituted pyrimidine 10a showed a highly agonistic effect on the 5-HT2C receptor, with excellent selectivity, as well as exceptional drug-like properties, including high plasma and microsomal stability, along with low CYP inhibition. Thus, pyrimidine 10a could be considered a viable lead compound as a 5-HT2C selective agonist.",
keywords = "5-HT receptor, Binding affinity, Cell-based assay, Disubstituted pyrimidine, Selectivity",
author = "Juhyeon Kim and Kim, {Yoon Jung} and Londhe, {Ashwini M.} and Pae, {Ae Nim} and Hyunah Choo and Kim, {Hak Joong} and Min, {Sun Joon}",
year = "2019",
month = "9",
day = "5",
doi = "10.3390/molecules24183234",
language = "English",
volume = "24",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "18",

}

TY - JOUR

T1 - Synthesis and biological evaluation of disubstituted pyrimidines as selective 5-HT2C agonists

AU - Kim, Juhyeon

AU - Kim, Yoon Jung

AU - Londhe, Ashwini M.

AU - Pae, Ae Nim

AU - Choo, Hyunah

AU - Kim, Hak Joong

AU - Min, Sun Joon

PY - 2019/9/5

Y1 - 2019/9/5

N2 - Here, we describe the synthesis of disubstituted pyrimidine derivatives and their biological evaluation as selective 5-HT2C agonists. To improve selectivity for 5-HT2C over other subtypes, we synthesized two series of disubstituted pyrimidines with fluorophenylalkoxy groups at either the 5-position or 4-position and varying cyclic amines at the 2-position. The in vitro cell-based assay and binding assay identified compounds 10a and 10f as potent 5-HT2C agonists. Further studies on selectivity to 5-HT subtypes and drug-like properties indicated that 2,4-disubstituted pyrimidine 10a showed a highly agonistic effect on the 5-HT2C receptor, with excellent selectivity, as well as exceptional drug-like properties, including high plasma and microsomal stability, along with low CYP inhibition. Thus, pyrimidine 10a could be considered a viable lead compound as a 5-HT2C selective agonist.

AB - Here, we describe the synthesis of disubstituted pyrimidine derivatives and their biological evaluation as selective 5-HT2C agonists. To improve selectivity for 5-HT2C over other subtypes, we synthesized two series of disubstituted pyrimidines with fluorophenylalkoxy groups at either the 5-position or 4-position and varying cyclic amines at the 2-position. The in vitro cell-based assay and binding assay identified compounds 10a and 10f as potent 5-HT2C agonists. Further studies on selectivity to 5-HT subtypes and drug-like properties indicated that 2,4-disubstituted pyrimidine 10a showed a highly agonistic effect on the 5-HT2C receptor, with excellent selectivity, as well as exceptional drug-like properties, including high plasma and microsomal stability, along with low CYP inhibition. Thus, pyrimidine 10a could be considered a viable lead compound as a 5-HT2C selective agonist.

KW - 5-HT receptor

KW - Binding affinity

KW - Cell-based assay

KW - Disubstituted pyrimidine

KW - Selectivity

UR - http://www.scopus.com/inward/record.url?scp=85071736554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071736554&partnerID=8YFLogxK

U2 - 10.3390/molecules24183234

DO - 10.3390/molecules24183234

M3 - Article

C2 - 31491978

AN - SCOPUS:85071736554

VL - 24

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 18

M1 - 3234

ER -